Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Amarin Corp Ads (NQ: AMRN )

5.830 USD UNCHANGED
Streaming Delayed Price Updated: 4:41 AM EST, Mar 4, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Amarin Corp Ads

< Previous 1 2 3 4 5 6 7 8 9
...
45 46 Next >
CLASS ACTION UPDATE for MU, AVEO, DPLO and AMRN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have... 
From GlobeNewswire News Releases
IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Amarin Corporation plc and Encourages Investors with Losses in Excess of $100,000 to Contact the
IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Amarin Corporation plc. 
From Business Wire News Releases
CLASS ACTION UPDATE for DNKEY, YRCW, TAP and AMRN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have... 
From GlobeNewswire News Releases
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of AVEO, MHLD, KHC and AMRN
The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these... 
From GlobeNewswire News Releases
Amarin Reports Record Fourth Quarter and Full Year 2018 Financial Results and Provides Update on Operations
Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on improving cardiovascular health, today announced financial results for the quarter and year ended December 31, 2018 and... 
From GlobeNewswire News Releases
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Amarin Corporation plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Fi
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Amarin Corporation plc. 
From Business Wire News Releases
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Amarin Corporation plc – AMRN
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Amarin Corporation plc (NASDAQ: AMRN) from September 24,... 
From Business Wire News Releases
CLASS ACTION UPDATE for PRGO, W, AMRN and VNDA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have... 
From GlobeNewswire News Releases
CLASS ACTION UPDATE for SOGO, W, ASTE and AMRN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have... 
From GlobeNewswire News Releases
Robbins Arroyo LLP: Amarin Corporation plc (AMRN) Sued for Misleading Shareholders
Shareholder rights law firm Robbins Arroyo LLP announces that purchasers of Amarin Corporation plc (NasdaqGM: AMRN) filed a class action complaint against the company for alleged violations of the... 
From Business Wire News Releases
CLASS ACTION UPDATE for ARLO, MKL, ATVI and AMRN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have... 
From GlobeNewswire News Releases
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of MU, MHLD, DPLO and AMRN
The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these... 
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amarin Corporation plc - AMRN
Pomerantz LLP is investigating claims on behalf of investors of Amarin Corporation plc ("Amarin" or the "Company") (NASDAQ: AMRN). Such investors are advised to contact Robert S. Willoughby at... 
From PR Newswire
CLASS ACTION UPDATE for YRIV, W, TAP and AMRN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have... 
From GlobeNewswire News Releases
AMARIN CORPORATION INVESTOR ALERT: Gibbs Law Group Files Class Action Lawsuit Alleging Violations of Federal Securities Laws
Gibbs Law Group files class action lawsuit on behalf of investors of Amarin Corporation (AMRN). 
From Business Wire News Releases
Amarin To Report Fourth Quarter and Full Year 2018 Results and Host Conference Call on February 27, 2019
Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on improving cardiovascular health, today announced that it will host a conference call with members of Amarin senior management... 
From GlobeNewswire News Releases
Amarin to Present at the 8th Annual SVB Leerink Global Healthcare Conference
Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today that John F. Thero,... 
From GlobeNewswire News Releases
Analysis: Positioning to Benefit within Amarin, Retrophin, Sunrun, BioSpecifics Technologies, Arbutus Biopharma, and TOCAGEN INC — Research Highlights Growth, Revenue, and Consolidated Results
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Amarin Corporation PLC... 
From GlobeNewswire News Releases
New REDUCE-IT™ Trial Data Showing the Total Reduction in Ischemic Events Accepted for Presentation at the American College of Cardiology’s 68th Annual Scientific Session
Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on improving cardiovascular health, announced that new data showing the reduction in total major adverse cardiovascular (i.e.,... 
From GlobeNewswire News Releases
Thinking about buying stock in Amarin Corporation, Activision Blizzard, Netflix, Precipio or Tilray?
InvestorsObserver issues critical PriceWatch Alerts for AMRN, ATVI, NFLX, PRPO, and TLRY. 
From PR Newswire
Amarin Provides Preliminary 2018 Results and 2019 Outlook
Amarin Corporation plc (NASDAQ:AMRN), today provided a business update, including a preliminary estimate of 2018 revenue results and 2019 revenue and spending guidance. Amarin plans to discuss these... 
From GlobeNewswire News Releases
Amarin to Present at 37th Annual J.P. Morgan Healthcare Conference on Wednesday, January 9, 2019
Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today that John F. Thero,... 
From GlobeNewswire News Releases
NASDAQ:AMRN Shareholder Notice: Investigation over Possible Securities Laws Violations by Amarin Corporation Plc
San Diego, CA -- (SBWIRE) -- 12/06/2018 -- Amarin Corporation is under investigation over potential securities laws violations by Amarin Corporation plc and certain of its directors and officers in... 
From SBWire - Latest Press Releases
Amarin to Participate in a Fireside Chat at Citi’s 2018 Global Healthcare Conference
Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today that John F. Thero,... 
From GlobeNewswire News Releases
Market Trends Toward New Normal in Amarin, BioSpecifics Technologies, Cavco Industries, Iconix Brand Group, A-Mark Precious Metals, and Core-Mark Holding — Emerging Consolidated Expectations, Analyst
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Amarin Corporation PLC... 
From GlobeNewswire News Releases
Amarin Prices Public Offering of American Depositary Shares
Amarin Corporation plc (NASDAQ: AMRN) today announced the pricing of the underwritten public offering of its American Depositary Shares ("ADSs") for gross proceeds of approximately $200.0 million,... 
From GlobeNewswire News Releases
Amarin Announces Proposed Public Offering of American Depositary Shares
Amarin Corporation plc (NASDAQ: AMRN) today announced a registered underwritten public offering of its American Depositary Shares (“ADSs”). All of the shares in the proposed offering are to be sold by... 
From GlobeNewswire News Releases
Amarin to Present at the Evercore ISI HealthCONx Conference
Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today that John F. Thero,... 
From GlobeNewswire News Releases
Key Pancreatic Cancer Therapy Developments Crucial in Combating World's Toughest Cancer
From PR Newswire
Key Pancreatic Cancer Therapy Developments Crucial in Combating World’s Toughest Cancer
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
< Previous 1 2 3 4 5 6 7 8 9
...
45 46 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.